Rosenberg Noah L. (CIK 0001579649)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: Chief Medical Officer
Shares held
47,614
Last filed at
Aug 17, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
589
Last filed at
Nov 25, 2025
Confidence Score
80.0
2025Q4
Confidence Score History
2025Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 25, 2025 Nov 25, 2025 Verrica Pharmaceuticals Inc. CMO Buy 90.0 +2,357 100.00% ✗ $10K
Aug 13, 2021 Aug 17, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 86.3 +3,093 6.95% ✗ $24.1K
Jul 28, 2021 Jul 29, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 45.0 -1,250 -2.73% ✓ $17.3K
May 11, 2021 May 13, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 48.8 -750 -1.62% ✓ $14.5K
Feb 5, 2021 Feb 9, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 37.5 -2,250 -4.63% ✓ $70.9K
Feb 3, 2021 Feb 3, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 37.5 -1,813 -3.95% ✓ $52.4K
Jan 31, 2021 Feb 2, 2021 Travere Therapeutics, Inc. Chief Medical Officer Sell 90.0 +3,187 7.46% ✓ $55.7K
Sep 23, 2020 Sep 23, 2020 Travere Therapeutics, Inc. Chief Medical Officer Sell 45.0 -750 -2.65% ✓ $13.9K
Sep 18, 2020 Sep 22, 2020 Travere Therapeutics, Inc. Chief Medical Officer Sell 86.3 +2,250 8.64% ✓ $13.9K
Jul 28, 2020 Jul 30, 2020 Travere Therapeutics, Inc. Chief Medical Officer Sell 46.3 -870 -3.23% ✗ $17.8K
May 12, 2020 May 13, 2020 Travere Therapeutics, Inc. Chief Medical Officer Sell 47.5 -527 -1.93% ✗ $9K
Mar 5, 2020 Mar 9, 2020 Travere Therapeutics, Inc. Chief Medical Officer Sell 91.3 +3,210 13.35% ✗ $27.5K
Jul 30, 2019 Jul 31, 2019 Travere Therapeutics, Inc. Chief Medical Officer Sell 23.8 -2,500 -15.63% ✓ $49.9K